The US Food and Drug Administration (FDA) on Monday detailed its plans to make it easier for companies developing direct-to-consumer (DTC) genetic health risk (GHR) tests to get those tests on the ...

Please provide your email address to receive an email when new articles are posted on . More than half of National Kidney Foundation respondents were unaware of genetic testing opportunities. Only 9% ...

Staying ahead of the curve on direct-to-consumer (DTC) genetic health risk (GHR) assessments, 23andMe became the first company with US Food and Drug Administration (FDA) marketing authorization for ...